Australian researchers are a step closer to developing a vaccine against malaria, a statement said on Friday.
Researchers from the Walter and Eliza Hall Institute have discovered a way to stop the malaria parasite invading healthy red blood cells, Xinhua news agency reported.
Professor Alan Cowman who led the study said in the statement that the malaria parasite could not penetrate a human red blood cell when key proteins were deleted.
"These findings hold great promise for understanding the function of these proteins and their development as vaccines," Cowman said.
"Developing new vaccines for malaria is a global research priority."
It was noted that approximately half the world's population is at risk of contracting malaria each year, with more than 200 million people infected.
Researchers also noted that existing anti-malarial drugs were becoming less effective as the malaria parasite developed resistance to treatments.
The disease kills up to 450,000 people each year, mainly children aged under five.
--IANS
ksk/dg
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
